Gallbladder Cancer Therapeutics Market, Global Outlook and Forecast 2022-2028

March 2022 | 64 pages | ID: GC1B9CA257CAEN
Market Monitor Global

Abstracts

Rising incidence of cholelithiasis, chronic inflammation of the gallbladder, and gallbladder polyps are contributing to the prevalence of gallbladder cancer. This has resulted in a rise in demand for therapeutics for treating the condition.

This report contains market size and forecasts of Gallbladder Cancer Therapeutics in Global, including the following market information:

Global Gallbladder Cancer Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Gallbladder Cancer Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Combination Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Gallbladder Cancer Therapeutics include Bristol-Myers Squibb Co., Eli Lilly and Co., F. Hoffmann-La Roche Ltd., Pfizer Inc. and Sanofi., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Gallbladder Cancer Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Gallbladder Cancer Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Gallbladder Cancer Therapeutics Market Segment Percentages, by Type, 2021 (%)

• Combination Therapy
• Monotherapy

Global Gallbladder Cancer Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Gallbladder Cancer Therapeutics Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Medical Research Institute
• Clinic
• Other

Global Gallbladder Cancer Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Gallbladder Cancer Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Gallbladder Cancer Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Gallbladder Cancer Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Bristol-Myers Squibb Co.
• Eli Lilly and Co.
• F. Hoffmann-La Roche Ltd.
• Pfizer Inc.
• Sanofi.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Gallbladder Cancer Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Gallbladder Cancer Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL GALLBLADDER CANCER THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Gallbladder Cancer Therapeutics Market Size: 2021 VS 2028
2.2 Global Gallbladder Cancer Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Gallbladder Cancer Therapeutics Players in Global Market
3.2 Top Global Gallbladder Cancer Therapeutics Companies Ranked by Revenue
3.3 Global Gallbladder Cancer Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Gallbladder Cancer Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Gallbladder Cancer Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Gallbladder Cancer Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Gallbladder Cancer Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Gallbladder Cancer Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Gallbladder Cancer Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 Combination Therapy
  4.1.3 Monotherapy
4.2 By Type - Global Gallbladder Cancer Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Gallbladder Cancer Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global Gallbladder Cancer Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global Gallbladder Cancer Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Gallbladder Cancer Therapeutics Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Medical Research Institute
  5.1.4 Clinic
  5.1.5 Other
5.2 By Application - Global Gallbladder Cancer Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Gallbladder Cancer Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global Gallbladder Cancer Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global Gallbladder Cancer Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Gallbladder Cancer Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Gallbladder Cancer Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Gallbladder Cancer Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global Gallbladder Cancer Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global Gallbladder Cancer Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Gallbladder Cancer Therapeutics Revenue, 2017-2028
  6.3.2 US Gallbladder Cancer Therapeutics Market Size, 2017-2028
  6.3.3 Canada Gallbladder Cancer Therapeutics Market Size, 2017-2028
  6.3.4 Mexico Gallbladder Cancer Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Gallbladder Cancer Therapeutics Revenue, 2017-2028
  6.4.2 Germany Gallbladder Cancer Therapeutics Market Size, 2017-2028
  6.4.3 France Gallbladder Cancer Therapeutics Market Size, 2017-2028
  6.4.4 U.K. Gallbladder Cancer Therapeutics Market Size, 2017-2028
  6.4.5 Italy Gallbladder Cancer Therapeutics Market Size, 2017-2028
  6.4.6 Russia Gallbladder Cancer Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries Gallbladder Cancer Therapeutics Market Size, 2017-2028
  6.4.8 Benelux Gallbladder Cancer Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Gallbladder Cancer Therapeutics Revenue, 2017-2028
  6.5.2 China Gallbladder Cancer Therapeutics Market Size, 2017-2028
  6.5.3 Japan Gallbladder Cancer Therapeutics Market Size, 2017-2028
  6.5.4 South Korea Gallbladder Cancer Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia Gallbladder Cancer Therapeutics Market Size, 2017-2028
  6.5.6 India Gallbladder Cancer Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Gallbladder Cancer Therapeutics Revenue, 2017-2028
  6.6.2 Brazil Gallbladder Cancer Therapeutics Market Size, 2017-2028
  6.6.3 Argentina Gallbladder Cancer Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Gallbladder Cancer Therapeutics Revenue, 2017-2028
  6.7.2 Turkey Gallbladder Cancer Therapeutics Market Size, 2017-2028
  6.7.3 Israel Gallbladder Cancer Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia Gallbladder Cancer Therapeutics Market Size, 2017-2028
  6.7.5 UAE Gallbladder Cancer Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Bristol-Myers Squibb Co.
  7.1.1 Bristol-Myers Squibb Co. Corporate Summary
  7.1.2 Bristol-Myers Squibb Co. Business Overview
  7.1.3 Bristol-Myers Squibb Co. Gallbladder Cancer Therapeutics Major Product Offerings
  7.1.4 Bristol-Myers Squibb Co. Gallbladder Cancer Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 Bristol-Myers Squibb Co. Key News
7.2 Eli Lilly and Co.
  7.2.1 Eli Lilly and Co. Corporate Summary
  7.2.2 Eli Lilly and Co. Business Overview
  7.2.3 Eli Lilly and Co. Gallbladder Cancer Therapeutics Major Product Offerings
  7.2.4 Eli Lilly and Co. Gallbladder Cancer Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 Eli Lilly and Co. Key News
7.3 F. Hoffmann-La Roche Ltd.
  7.3.1 F. Hoffmann-La Roche Ltd. Corporate Summary
  7.3.2 F. Hoffmann-La Roche Ltd. Business Overview
  7.3.3 F. Hoffmann-La Roche Ltd. Gallbladder Cancer Therapeutics Major Product Offerings
  7.3.4 F. Hoffmann-La Roche Ltd. Gallbladder Cancer Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 F. Hoffmann-La Roche Ltd. Key News
7.4 Pfizer Inc.
  7.4.1 Pfizer Inc. Corporate Summary
  7.4.2 Pfizer Inc. Business Overview
  7.4.3 Pfizer Inc. Gallbladder Cancer Therapeutics Major Product Offerings
  7.4.4 Pfizer Inc. Gallbladder Cancer Therapeutics Revenue in Global Market (2017-2022)
  7.4.5 Pfizer Inc. Key News
7.5 Sanofi.
  7.5.1 Sanofi. Corporate Summary
  7.5.2 Sanofi. Business Overview
  7.5.3 Sanofi. Gallbladder Cancer Therapeutics Major Product Offerings
  7.5.4 Sanofi. Gallbladder Cancer Therapeutics Revenue in Global Market (2017-2022)
  7.5.5 Sanofi. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Gallbladder Cancer Therapeutics Market Opportunities & Trends in Global Market
Table 2. Gallbladder Cancer Therapeutics Market Drivers in Global Market
Table 3. Gallbladder Cancer Therapeutics Market Restraints in Global Market
Table 4. Key Players of Gallbladder Cancer Therapeutics in Global Market
Table 5. Top Gallbladder Cancer Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Gallbladder Cancer Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Gallbladder Cancer Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Gallbladder Cancer Therapeutics Product Type
Table 9. List of Global Tier 1 Gallbladder Cancer Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gallbladder Cancer Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Gallbladder Cancer Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Gallbladder Cancer Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Gallbladder Cancer Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Gallbladder Cancer Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Gallbladder Cancer Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Gallbladder Cancer Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Gallbladder Cancer Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Gallbladder Cancer Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Gallbladder Cancer Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Gallbladder Cancer Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Gallbladder Cancer Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Gallbladder Cancer Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Gallbladder Cancer Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Gallbladder Cancer Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Gallbladder Cancer Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Gallbladder Cancer Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Gallbladder Cancer Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Gallbladder Cancer Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Gallbladder Cancer Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Bristol-Myers Squibb Co. Corporate Summary
Table 31. Bristol-Myers Squibb Co. Gallbladder Cancer Therapeutics Product Offerings
Table 32. Bristol-Myers Squibb Co. Gallbladder Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Eli Lilly and Co. Corporate Summary
Table 34. Eli Lilly and Co. Gallbladder Cancer Therapeutics Product Offerings
Table 35. Eli Lilly and Co. Gallbladder Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. F. Hoffmann-La Roche Ltd. Corporate Summary
Table 37. F. Hoffmann-La Roche Ltd. Gallbladder Cancer Therapeutics Product Offerings
Table 38. F. Hoffmann-La Roche Ltd. Gallbladder Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Pfizer Inc. Corporate Summary
Table 40. Pfizer Inc. Gallbladder Cancer Therapeutics Product Offerings
Table 41. Pfizer Inc. Gallbladder Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Sanofi. Corporate Summary
Table 43. Sanofi. Gallbladder Cancer Therapeutics Product Offerings
Table 44. Sanofi. Gallbladder Cancer Therapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Gallbladder Cancer Therapeutics Segment by Type in 2021
Figure 2. Gallbladder Cancer Therapeutics Segment by Application in 2021
Figure 3. Global Gallbladder Cancer Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Gallbladder Cancer Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Gallbladder Cancer Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Gallbladder Cancer Therapeutics Revenue in 2021
Figure 8. By Type - Global Gallbladder Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Gallbladder Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Gallbladder Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Gallbladder Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Gallbladder Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Gallbladder Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Gallbladder Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Gallbladder Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Gallbladder Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Gallbladder Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Gallbladder Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Gallbladder Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Gallbladder Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Gallbladder Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Gallbladder Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Gallbladder Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Gallbladder Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Gallbladder Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Gallbladder Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Gallbladder Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Gallbladder Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Gallbladder Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Gallbladder Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Gallbladder Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Gallbladder Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Gallbladder Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Gallbladder Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Gallbladder Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Gallbladder Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Bristol-Myers Squibb Co. Gallbladder Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Eli Lilly and Co. Gallbladder Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. F. Hoffmann-La Roche Ltd. Gallbladder Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Pfizer Inc. Gallbladder Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Sanofi. Gallbladder Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)